Growth factor signaling and angiogenesis may promote endocrine-resistance in breast cancer and blocking these pathways can overcome resistance in preclinical models. We conducted a phase-II study of

NIAID Data Ecosystem10

Table_1_ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC.xlsx

肿瘤免疫治疗生物标志物

肺癌预后

Immunotherapy by immune checkpoint inhibitors (ICIs) has showed outstanding efficacy in the treatment of advanced non-small cell lung cancer (NSCLC). The combination of immunotherapy with anti-angioge

NIAID Data Ecosystem40

Clinicopathological parameters and quality scores of studies comparingMTA1 positive digestive tract cancer with MTA1 negative digestive tract cancer.

肿瘤生物标志物分析

消化系统癌症病理

Clinicopathological parameters and quality scores of studies comparingMTA1 positive digestive tract cancer with MTA1 negative digestive tract cancer.

NIAID Data Ecosystem10